Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity

Background. The benefit of dose-escalated hypofractionated radiotherapy using intensity-modulated radiotherapy (IMRT) in prostate cancer is not established. We report 5-year outcome and long-term toxicity data within a phase II clinical trial. Materials and Methods. 60 men with predominantly high-ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomson, David, Merrick, Sophie, Swindell, Ric, Coote, Joanna, Kelly, Kay, Stratford, Julie, Wylie, James, Cowan, Richard, Elliott, Tony, Logue, John, Choudhury, Ananya, Livsey, Jacqueline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388303/
https://www.ncbi.nlm.nih.gov/pubmed/22792470
http://dx.doi.org/10.1155/2012/450246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388303/
https://www.ncbi.nlm.nih.gov/pubmed/22792470
http://dx.doi.org/10.1155/2012/450246

Ejemplares similares